Parallel CD19/CD20 CAR-Activated T-Cells Are More Effective for Refractory B-Cell Lymphoma In Vitro and In Vivo
- Type
- Retraction
- Notice date
- 6/21/2023 0:00
- Journal
- Evidence-Based Complementary and Alternative Medicine
- Publisher
- Hindawi
- Notice DOI
- 10.1155/2023/9824923
- Original paper DOI
- 10.1155/2022/1227308